HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Resveratrol inhibits paraquat-induced oxidative stress and fibrogenic response by activating the nuclear factor erythroid 2-related factor 2 pathway.

Abstract
Nuclear factor erythroid 2-related factor 2 (Nrf2) is an antioxidant-activated transcription factor that recently emerged as a critical regulator of cellular defense against oxidative and inflammatory lesions. Resveratrol (Res) is a natural phytoalexin that exhibits multiple therapeutic potentials, including antioxidative and anti-inflammatory effects in animals. Paraquat (PQ) is the second most widely used herbicide worldwide, but it selectively accumulates in human lungs to cause oxidative injury and fibrosis with high mortality. Here, we analyzed the molecular mechanism of the fibrogenic response to PQ and its inhibition by Res and Nrf2. PQ dose-dependently caused toxicity in normal human bronchial epithelial cells (BEAS-2B), resulting in mitochondrial damage, oxidative stress, and cell death. Res at 10 μM markedly inhibited PQ toxicity. PQ at 10 μM stimulated production of inflammatory and profibrogenic factors (tumor necrosis factor α, interleukin 6, and transforming growth factor β1) and induced the transformation of normal human lung fibroblasts (WI38-VA13) to myofibroblasts; both effects were inhibited by Res. Res strongly activated the Nrf2 signaling pathway and induced antioxidant response element-dependent cytoprotective genes. On the other hand, knockout or knockdown of Nrf2 markedly increased PQ-induced cytotoxicity, cytokine production, and myofibroblast transformation and abolished protection by Res. The findings demonstrate that Res attenuates PQ-induced reactive oxygen species production, inflammation, and fibrotic reactions by activating Nrf2 signaling. The study reveals a new pathway for molecular intervention against pulmonary oxidative injury and fibrosis.
AuthorsXiaoqing He, Liping Wang, Grazyna Szklarz, Yongyi Bi, Qiang Ma
JournalThe Journal of pharmacology and experimental therapeutics (J Pharmacol Exp Ther) Vol. 342 Issue 1 Pg. 81-90 (Jul 2012) ISSN: 1521-0103 [Electronic] United States
PMID22493042 (Publication Type: Journal Article)
Chemical References
  • Antioxidants
  • Interleukin-6
  • NF-E2-Related Factor 2
  • Reactive Oxygen Species
  • Stilbenes
  • Transforming Growth Factor beta1
  • Tumor Necrosis Factor-alpha
  • Paraquat
  • Resveratrol
Topics
  • Animals
  • Antioxidants (metabolism)
  • Apoptosis (drug effects, genetics)
  • Cell Death (drug effects, genetics)
  • Cells, Cultured
  • Cytoprotection (drug effects, genetics)
  • Epithelial Cells (drug effects, metabolism)
  • Fibroblasts (drug effects, metabolism)
  • Humans
  • Inflammation (drug therapy, metabolism)
  • Interleukin-6 (genetics, metabolism)
  • Mice
  • Mice, Knockout
  • Mitochondria (drug effects, genetics, metabolism)
  • Myofibroblasts (drug effects, metabolism)
  • NF-E2-Related Factor 2 (antagonists & inhibitors, genetics, metabolism)
  • Oxidative Stress (drug effects, genetics)
  • Paraquat (antagonists & inhibitors, pharmacology)
  • Reactive Oxygen Species (metabolism)
  • Response Elements (drug effects, genetics)
  • Resveratrol
  • Signal Transduction (drug effects, genetics)
  • Stilbenes (pharmacology)
  • Transforming Growth Factor beta1 (genetics, metabolism)
  • Tumor Necrosis Factor-alpha (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: